Abstract 298P
Background
Abandonment of treatment is a poorly recognized issue, common in the unique group of Teenage and Young Adults (TYAs) (15-29 y) with cancer. Cancer in this age group causes social and psychological turmoil altering their understanding and perception about the management of cancer. This study is the first-of-its kind in TYAs while there are several pediatric reports on the problem.
Methods
A retrospective cross-sectional and analytical study was conducted over a period of 18 months from 01st January 2017 to 30thJune 2018 with a 12-month registration period and 6 months of follow up at four cancer centers in Rajasthan (3) and Madhya Pradesh (1). A total of 1310 TYA cancer patients’ charts were analyzed to study the influence of demographic and disease-related characteristics associated with the abandonment of treatment in TYAs with cancer. Complete data of 807 patients (55.8%) was collected.
Results
Factors leading to abandonment were analyzed, and the salient conclusions are that - Total of 650 patients (80.5%) were from the rural background and most of the patients (88%) were living more than 200 kilometers from oncology centers. A quarter (24.4%) of all TYAs with cancer abandoned their therapy: mostly students, unemployed and unmarried. Those with bone cancer (37%), brain tumor (31.6%) and leukemia (25.1%) had the highest abandonment rate. Reasons for abandonment identified were financial burden of therapy, followed by the refusal of standard therapy and preference for alternative medicine. Mortality rates were Forty six percent in our study group with similar outcome across all age groups. There were significantly more deaths in patients who abandoned treatment. (30.4% vs 18.6%).
Conclusions
Our study has for the first-time quantified abandonment of treatment among TYA cancer patients: a quarter of all cancers. Completing treatment decreases the probability of death from cancer. Conducting a large, community level collaborative study will probably be more informative and could validate these and other characteristics of this unique demographic group of cancer patients, with clues to reduce or prevent abandonment.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
285P - Comparison of induction chemotherapy plus concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: A meta-analysis
Presenter: Xu Guoqiang
Session: e-Poster Display Session
286P - Improved diagnostic accuracy on MR imaging in post-surgical recurrent head and neck SCC lesions using decision tree classification system
Presenter: Ankush Jajodia
Session: e-Poster Display Session
287P - Establishment of nasopharyngeal carcinoma organoid culture system and preliminary exploration of drug sensitivity test in vitro
Presenter: Wang Wen
Session: e-Poster Display Session
288P - Application of volumetric modulated arc therapy (VMAT) in head and neck cancers: 5-year single institutional experience
Presenter: Hiep Doan
Session: e-Poster Display Session
289P - Radiotherapy in advanced nasopharyngeal carcinoma
Presenter: Chih Kiang Tan
Session: e-Poster Display Session
292P - Shared decision-making at the cancer institute adult outpatient clinics of a tertiary hospital in the Philippines: A cross sectional study
Presenter: Marvin Jonne Mendoza
Session: e-Poster Display Session
293P - Prolonged release (PR) oxycodone/naloxone (OXN) for cancer pain (CP) & its impact on bowel function, safety & quality of life (QoL): Systematic review
Presenter: Sam Hjelmeland Ahmedzai
Session: e-Poster Display Session
294P - Interventional pain treatment in patients with pain syndrome in advanced tumours of small pelvis
Presenter: Yakhyo Ziyaev
Session: e-Poster Display Session
295P - Assessment of the impact of palliative care on the quality of life in advanced non-small cell lung cancer patients
Presenter: Sabin Katpattil
Session: e-Poster Display Session
296P - Outcomes of repeat transhepatic percutaneous biliary drainage in patients presenting with recurrent malignant biliary stricture
Presenter: Deevia Hanji
Session: e-Poster Display Session